Repaglinide

CAS 135062-02-1 18 FDA-DMF suppliersSmall Molecule

Overview

Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.

API suppliers (28)

Suppliers of Repaglinide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Sun Pharmaceutical Industries LimitedIndia1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • USV PRIVATE LTD1 active DMF
  • JUBILANT BIOSYS LTD1 active DMF
  • Torrent PharmaceuticalsIndia1 active DMF
  • BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
  • USV PRIVATE LTD1 active DMF
  • Biocon LimitedIndia1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • Sun Pharmaceutical Industries LimitedIndia1 active DMF
  • USV PRIVATE LTD1 active DMF
  • Biocon LimitedIndia1 active DMF
  • BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
  • Macleods Pharmaceuticals Ltd.India1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • Sun Pharmaceutical Industries LimitedIndia1 active DMF
  • USV PRIVATE LTD1 active DMF
  • Biocon LimitedIndia1 active DMF
  • BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
  • Macleods Pharmaceuticals Ltd.India1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • JUBILANT BIOSYS LTD1 active DMF
  • Torrent PharmaceuticalsIndia1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China
  • Zakłady Farmaceutyczne Polpharma S.A.Poland

Showing 25 of 28 suppliers — see the full list in the app.

Therapeutic areas

DiabetesEndocrinology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.